You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新華製藥(000756.SZ):以掛牌價1590.68萬元取得萬博化工27%股權
格隆匯 04-20 17:05

格隆匯4月20日丨新華製藥(000756.SZ)公佈,2020年3月20日,公司第九屆董事會第十次會議審議通過了《關於擬競標山東新華萬博化工有限公司27%股權關聯交易的議案》。

山東新華萬博化工有限公司27%股權通過山東產權交易中心公開掛牌後,截止公開掛牌最後期限,因只徵集到一家受讓方(公司),轉讓方決定以協議轉讓方式實施轉讓。公司以掛牌價人民幣1590.6834萬元取得標的股權。2020年4月20日,公司與華魯控股集團有限公司簽訂了產權交易合同。

公司將根據有關規定,儘快完成萬博化工27%股權的變更手續。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account